ArticleEuropean geriatric medicine2025
Identifying risk factors for sarcopenia using machine learning: insights from multimodal data.
Article in European geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Distribution of Muscle Mass and Fat Mass to Identify the Risk of Sarcopenia and Sarcopenic Obesity in Adults via Machine Learning.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThis study aims to identify key risk factors for sarcopenia using machine learning models, leveraging anthropometric, biochemical, functional, nutritional, and genetic data. By developing predictive models, the research seeks to improve early detection, enhance diagnostic accuracy, and facilitate personalized interventions for individuals at risk of sarcopenia.
methodsWe analysed multimodal data from 484 older adults. Two scenarios: Set-a (including SARC-CalF, excluding SARC-F) and Set-b (including SARC-F, excluding SARC-CalF) were applied in a three-stage modeling process with progressively reduced features and optimized predictive performance using machine learning models. Key predictors were ranked using SHAP values, and model performance was evaluated using AUC, accuracy, sensitivity, and specificity. Internal validation and DeLong's test were applied to assess robustness and statistical differences.
resultsThe most predictive risk factors included functional measures (chair stand, gait speed), nutritional indicators (protein, folate, copper, vitamin B7), clinical conditions (diabetes, comorbidities, low-density lipoprotein (LDL)), and anthropometric markers (body mass index (BMI), calf circumference). Genetic features also contributed to risk stratification. The best-performing model Set-b (with screening test SARC-F) achieved an AUC of 0.951 and an accuracy of 93.62%. While SARC-CalF showed higher individual feature importance, the model achieved an AUC of 0.945 and accuracy of 92.2%.
conclusionsThis study highlights that traditional sarcopenia screening can be enhanced by capturing complex interplay of functional, nutritional, clinical, and genetic factors, offering clinicians a more accurate and tailored tool for early detection and risk stratification. Future research should focus on validating these models in larger, independent, and longitudinal cohorts to assess their predictive utility across diverse populations and over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.